The ATRC in the Department of Neurology at Massachusetts General Hospital serves as a molecular and anatomic neuropathology resource for the Boston neuroscience community.
Department of Neurology Research Labs
Our research group is focused on risk estimation, treatment and prevention of age-related brain deterioration.
The Albers Laboratory uses the olfactory system of mice and humans to explore early pathologic events of neurodegeneration.
We take a multidisciplinary, basic science to clinic translational approach to designing patient-oriented experimental and clinical trials for aging, dementia, and other neurodegenerative disorders.
The Array Tomography Core, part of the Neurosciences Center at Massachusetts General Hospital, offers array tomography imaging services and in vivo multiphoton imaging.
Borrowing from successes in cancer drug development, the Healey Center and NEALS faculty are leading the first ALS Platform Trial.
Brian Bacskai's laboratory uses sophisticated optical techniques to address fundamental questions in Alzheimer's disease research.
The Badr lab is focused on studying the genetic drivers of malignancy and treatment resistance as well as developing targeted and experimental therapeutics for brain tumors.
The research goal of Dr. Oksana Berezovska's lab is to study the cellular and molecular mechanisms of Alzheimer's disease pathology.
The Biorepository for Neurological Injury provides data to help researchers understand how genes and other factors contribute to risk of brain disease, recovery from brain injuries and the maintenance of a healthy brain.
Transforming Medicine Through Innovation
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.